Warner-Lambert Halls worldwide sales rise 11% to $135 mil. in third quarter.
This article was originally published in The Tan Sheet
Executive Summary
HALLS COUGH TABLET WORLDWIDE SALES RISE 11% TO $135 MIL. in the third quarter, Warner-Lambert said in an Oct. 19 release. Sales for the brand contributed to an 8% gain to $870 mil. in worldwide sales for Warner-Lambert's consumer health care segment. The company continues to expand the brand with the launch of Halls Juniors sugar-free cough drops for children this fall.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: